PortfoliosLab logoPortfoliosLab logo
XHS vs. CANC
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

XHS vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Health Care Services ETF (XHS) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

XHS vs. CANC - Yearly Performance Comparison


2026 (YTD)20252024202320222021
XHS
SPDR S&P Health Care Services ETF
-6.26%18.83%1.76%5.15%-19.87%1.84%
CANC
Tema Oncology ETF
5.69%42.92%-5.37%510.51%-85.34%-51.82%

Returns By Period

In the year-to-date period, XHS achieves a -6.26% return, which is significantly lower than CANC's 5.69% return.


XHS

1D
1.87%
1M
-7.51%
YTD
-6.26%
6M
-1.26%
1Y
2.34%
3Y*
5.33%
5Y*
-1.07%
10Y*
6.53%

CANC

1D
4.66%
1M
-2.88%
YTD
5.69%
6M
27.93%
1Y
52.46%
3Y*
140.00%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


XHS vs. CANC - Expense Ratio Comparison

XHS has a 0.35% expense ratio, which is lower than CANC's 0.75% expense ratio.


Return for Risk

XHS vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XHS
XHS Risk / Return Rank: 1616
Overall Rank
XHS Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
XHS Sortino Ratio Rank: 1515
Sortino Ratio Rank
XHS Omega Ratio Rank: 1515
Omega Ratio Rank
XHS Calmar Ratio Rank: 1717
Calmar Ratio Rank
XHS Martin Ratio Rank: 1818
Martin Ratio Rank

CANC
CANC Risk / Return Rank: 9090
Overall Rank
CANC Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CANC Sortino Ratio Rank: 9090
Sortino Ratio Rank
CANC Omega Ratio Rank: 8282
Omega Ratio Rank
CANC Calmar Ratio Rank: 9494
Calmar Ratio Rank
CANC Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XHS vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Services ETF (XHS) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XHSCANCDifference

Sharpe ratio

Return per unit of total volatility

0.12

1.94

-1.82

Sortino ratio

Return per unit of downside risk

0.30

2.59

-2.29

Omega ratio

Gain probability vs. loss probability

1.04

1.32

-0.29

Calmar ratio

Return relative to maximum drawdown

0.25

3.86

-3.61

Martin ratio

Return relative to average drawdown

0.68

13.76

-13.08

XHS vs. CANC - Sharpe Ratio Comparison

The current XHS Sharpe Ratio is 0.12, which is lower than the CANC Sharpe Ratio of 1.94. The chart below compares the historical Sharpe Ratios of XHS and CANC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


XHSCANCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.12

1.94

-1.82

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.05

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

0.52

-0.04

+0.56

Correlation

The correlation between XHS and CANC is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

XHS vs. CANC - Dividend Comparison

XHS's dividend yield for the trailing twelve months is around 0.29%, more than CANC's 0.05% yield.


TTM20252024202320222021202020192018201720162015
XHS
SPDR S&P Health Care Services ETF
0.29%0.27%0.38%0.23%0.19%0.20%0.23%2.37%0.34%0.22%0.28%0.93%
CANC
Tema Oncology ETF
0.05%0.06%3.00%0.56%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

XHS vs. CANC - Drawdown Comparison

The maximum XHS drawdown since its inception was -39.32%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for XHS and CANC.


Loading graphics...

Drawdown Indicators


XHSCANCDifference

Max Drawdown

Largest peak-to-trough decline

-39.32%

-97.53%

+58.21%

Max Drawdown (1Y)

Largest decline over 1 year

-12.61%

-12.40%

-0.21%

Max Drawdown (5Y)

Largest decline over 5 years

-32.62%

Max Drawdown (10Y)

Largest decline over 10 years

-39.32%

Current Drawdown

Current decline from peak

-12.33%

-56.19%

+43.86%

Average Drawdown

Average peak-to-trough decline

-10.27%

-73.91%

+63.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

3.61%

+0.92%

Volatility

XHS vs. CANC - Volatility Comparison

The current volatility for SPDR S&P Health Care Services ETF (XHS) is 4.98%, while Tema Oncology ETF (CANC) has a volatility of 8.36%. This indicates that XHS experiences smaller price fluctuations and is considered to be less risky than CANC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


XHSCANCDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.98%

8.36%

-3.38%

Volatility (6M)

Calculated over the trailing 6-month period

12.45%

16.34%

-3.89%

Volatility (1Y)

Calculated over the trailing 1-year period

19.25%

27.24%

-7.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.05%

285.66%

-264.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.41%

285.66%

-263.25%